| 3i Group |
Kirchhoff Consult |
| 4SC AG |
Landsbanki Kepler |
| Abingworth Management Limited |
Lectus Therapeutics Ltd. |
| Adamant Biomedical Investments |
LifeCycle Pharma A/S |
| Adamant Ventures |
Lombard Odier Darier Hentsch & Cie |
| Addex Pharmaceuticals Ltd |
Lumavita AG |
| Aescap Venture |
MC Services |
| Agendia |
Medeor Associates |
| Ambrilia Biopharma Inc. |
Medicyte GmbH |
| Aravis Venture Associates AG |
Merck & Co. |
| Archimedes Pharma Ltd. |
Merck Serono International S.A. |
| Atlas Venture |
Merck Serono SA |
| Avir Green Hills Biotechnology AG |
Molecular Partners AG |
| Axentis Pharma AG |
MolMed S.p.A |
| Axial Biotech, Inc. |
Morgan Stanley |
| Baigo Capital GmbH |
N.M Rothschild & Sons Ltd |
| Bank Sarasin & Cie AG |
Nextech Venture |
| BankInvest Biomedical Venture |
Nitec Pharma AG |
| BB Biotech Ventures |
Novartis International AG |
| Bell Pottinger Switzerland |
Novartis Pharmaceuticals |
| Biocrates Life Sciences GmbH |
Novo A/S |
| BioMedPartners |
Paul Capital Partners |
| Biotie Therapies Corp. |
Pfizer, Inc. |
| BioXell |
PharmaVentures Ltd. |
| Bloomberg News |
PharmaWave Ltd |
| Bridgehead International |
PricewaterhouseCoopers AG |
| Bristol-Myers Squib |
Pronota N.V. |
| Cambridge Consultants Ltd |
Provecs Medical GmbH |
| Canaccord Adams |
PWC Consulting |
| Cederberg Advisors |
ReNeuron Group plc |
| Cellerix SA |
Roche Venture Fund |
| Clinuvel |
Rothschild & Cie |
| College Hill |
Sager Pharma Kft. |
| Credit Suisse |
Sal. Oppenheim Jr. & Cie |
| DBV Technologies |
Scil Technology GmbH |
| Debiopharm Group |
Selvita Sp. z o.o. |
| Dompé International SA |
SIX Swiss Exchange AG |
| Dresdner Kleinwort |
Sofinnova Partners |
| DyoDelta Biosciences |
SpinX Technologies |
| Edmond de Rothschild Investment Partners |
Staatz Business Development & Strategy |
| Equity Development Ltd. |
Swiss Biotech |
| ESBATech AG |
Syntaxin Ltd |
| Esteve Group |
tecData AG |
| EVA - the Basel life sciences start-up agency |
Trout Group International LLC |
| Evolva SA |
Union Bancaire Privée |
| Excellentia Global Partners |
United Technologies AG |
| FCMB Aps |
Ventech |
| FIBREX Medical GmbH |
Venture Valuation AG |
| Forbion Capital Partners |
VIVUS, Inc. |
| Global Life Science Ventures |
Wilex AG |
| Global Life Science Ventures AG |
Xceleron Ltd. |
| Green Hills Biotechnology GmbH |
Xceleron, Inc. |
| HBM Partners AG |
Ysios Capital Partners SGECR SA |
| Helsinn Healthcare SA |
Zürcher Kantonalbank |
| Helvea SA |
|
| Herbonis AG |
|
| Hitec Capital SA |
|
| Hoffmann-La Roche Ltd. |
|
| immatics biotechnologies GmbH |
|
| ImVisioN GmbH |
|
| Index Ventures |
|
| INVEST SECURITIES |
|